"Fifth Plant Effect" Samsung Biologics Target Price at KRW 2.3 Million... Hyundai Glovis Delivers Stable Results Across All Divisions [Stocktopia]

\r\n
[The Financial News] On the morning of January 22, we summarize key reports from major securities firms.
Samsung Biologics has effectively relaunched its business structure with a focus on contract development and manufacturing organization (CDMO) services, driven by the full-scale operation of its fifth plant. Hyundai Glovis is expected to deliver strong results across its logistics, shipping, and distribution divisions, achieving annual operating profit of KRW 2.076 trillion and offering strong prospects for dividend growth. Kumho Petrochemical is likely to secure new demand for synthetic rubber as the Physical AI industry, centered on Robotics and autonomous driving, continues to expand.
\r\n\r\n◆Samsung Biologics (207940)― Meritz Securities / Analyst Kim Jun-young
- Target price: KRW 2.3 million (raised from KRW 2.1 million)
- Investment opinion: Buy
Meritz Securities raised its target price for Samsung Biologics from KRW 2.1 million to KRW 2.3 million, while maintaining a Buy rating, reflecting the expected benefits from the full-scale operation of the fifth plant. Analyst Kim Jun-young noted that with plants 1 to 4 running at full capacity and the fifth plant beginning to contribute revenue, these factors should underpin the company’s performance, leading to an estimated 17.4% increase in revenue compared with last year. Kim also pointed out that, as demand shifts away from China following the implementation of the Biosecurity Act, Samsung Biologics’ transition to a pure-play CDMO structure through a spin-off and its efforts to secure a manufacturing base in the United States are likely to positively influence future order growth. He added that revenue from GlaxoSmithKline plc (GSK)’s U.S. plant has not yet been reflected, leaving room for a further upward revision of the target price once the transaction is completed.※ CDMOCDMO stands for Contract Development and Manufacturing Organization, a business model in which companies take on drug development and manufacturing on behalf of pharmaceutical firms. Companies like Samsung Biologics, which operate large-scale production facilities, manufacture biopharmaceuticals for global drug makers under this model.
\r\n\r\n◆Hyundai Glovis (086280)― LS Securities / Analyst Lee Jae-hyuk
- Target price: KRW 320,000 (raised from KRW 220,000)
- Investment opinion: Buy
LS Securities raised its target price for Hyundai Glovis from KRW 220,000 to KRW 320,000, maintaining a Buy rating based on solid performance across its logistics, shipping, and distribution businesses. Analyst Lee Jae-hyuk analyzed that global seaborne finished-vehicle volumes returned to a growth trajectory in the second half of last year after overcoming tariff concerns in the first half. He highlighted that export volumes of finished vehicles from China, in particular, are clearly on the rise, and stressed that, with the introduction of separate taxation on dividend income, Hyundai Glovis’ consistent commitment to shareholder returns and clear visibility on dividend growth remain key attractions.
\r\n\r\n◆Kumho Petrochemical (011780)― Korea Investment & Securities / Analyst Lee Chung-jae
- Target price: Not provided
- Investment opinion: Not provided
Korea Investment & Securities expects Kumho Petrochemical to benefit from the growth of the Physical AI industry, which is driven by two main pillars: Robotics and autonomous driving. Analyst Lee Chung-jae explained that the synthetic rubber industry currently derives about 60–65% of its demand from the automotive sector, but robots are emerging as a new demand source. Synthetic rubber is a key material used to manufacture essential robot components such as gaskets, seals, pads, and grippers. Lee added that synthetic rubber producers are securing the robot industry as a new end-market, while climate change is increasing volatility in natural rubber harvests.※ Physical AIPhysical AI refers to artificial intelligence that operates in the physical world, mainly in systems such as robots and autonomous vehicles that move and perform tasks in real-world environments. Unlike AI that exists only on screens, robots that move and act in reality are a representative example.
\r\n\r\n
sms@fnnews.com Reporter Sung Min-seo Reporter